Free public records show Healthgen Biotechnology Corp. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Healthgen Biotechnology Corp. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by Healthgen Biotechnology Corp., of 8 in all
Source: ClinicalTrials.gov, Studies with Healthgen Biotechnology Corp. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Healthgen Biotechnology Corp. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Healthgen Biotechnology Corp. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Healthgen Biotechnology Corp.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Healthgen Biotechnology Corp. is in.
Stories on the topics Healthgen Biotechnology Corp. works in.
More than half of deaths in low- and middle-income countries come from conditions emergency care could treat…
Read
Road crashes kill about 1.16 million people a year, and more than half of deaths in poorer countries come…
Read
Keeping the airway open is the first step in saving a life. More than half of deaths in low- and…
ReadSearch all reports for Healthgen Biotechnology Corp. All companies